ClinicalTrials.gg
CompletedNCT02923362ROARSUpdated Aug 7, 2026

Registry of Outcomes From AntiReflux Surgery

An observational study in Gastroesophageal Reflux Disease and Hiatal Hernia, sponsored by The Heartburn Foundation. Completed at 19 sites in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by The Heartburn Foundation · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,941
Ages
21 Years and older
Sex
All
01

Study summary

Prospective registry comparing outcomes after laparoscopic treatment of gastroesophageal reflux disease and hiatal hernia.

Read the detailed description

This is a prospective, multi center, observational database of patients that are having surgical laparoscopic antireflux procedure and/or hiatal hernia repair, including laparoscopic Nissen fundoplication and Magnetic Sphincter Augmentation with the LINX device. Patients meeting registry inclusion and exclusion will be followed for 5 years with standardized quality of life surveys and appropriate standard of care testing. Up to 40 sites will participate with total enrollment of 1000 patients.

The main objectives are to collect data from everyday clinical practices and track patients from preoperative assessments to 5 years post surgical intervention to evaluate symptoms, medication use and side effects.

02

Conditions studied

  • Gastroesophageal Reflux Disease
  • Hiatal Hernia

Keywords

  • GERD
  • Reflux
  • Acid Reflux
  • Heartburn
  • Regurgitation
  • Laryngopharyngeal Reflux
  • Hiatal Hernia
  • LPR
  • LINX
  • Magnetic Sphincter Augmentation
  • Antireflux Surgery
  • Nissen
03

In context

Gastroesophageal Reflux

1,211 studies on the registry are indexed under Gastroesophageal Reflux; 202 are open to participants now.

This study's enrollment of 1,941 is above the median of 178 across 348 observational studies indexed under Gastroesophageal Reflux.

Browse Gastroesophageal Reflux studies →

Lead sponsor

This is the only study on the registry with The Heartburn Foundation as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Male and female patient over the age of 21 with no maximum age who meet the eligibility for anti reflux and or hiatal hernia repair surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject must be at least 21years of age and at least the minimum Age of Majority according to applicable state law.
  • Subject is a suitable surgical candidate, i.e. is able to undergo appropriate anesthesia and endoscopic procedure or laparoscopic surgery.
  • Appropriate indications for and documentation of disease process requiring surgery. (Documented gastroesophageal reflux disease by accepted endoscopic or ambulatory reflux monitoring criteria, or have a hiatal hernia that meets accepted criteria for repair (e.g. large paraesophageal hernia with chest pain)).
  • Subject is willing and able to cooperate with follow-up examinations
  • Subject has been informed of the study procedures and treatment and has signed an for the study.

Exclusion criteria

Exclusion Criteria:

  • Suspected or confirmed esophageal or gastric cancer.
  • Cannot understand trial requirements or is unable to comply with follow-up schedule
  • Pregnant or nursing, or plans to become pregnant during the course of the study
  • Medical illness (i.e. congestive heart failure) that may cause the subject to be non-compliant with or able to meet the protocol requirements or is associated with limited (i.e. less than 3 years)
  • Diagnosed psychiatric disorder (e.g. bipolar, schizophrenia, etc.), subjects that exhibit depression that are on appropriate medication(s) are allowable.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,941 participants (actual)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Laparoscopic Fundoplication Group

    This group of patients are surgical candidates based on preoperative testing results for laparoscopic fundoplication antireflux procedure and possible hiatal hernia repair.

  • LINX Antireflux Device Group

    This group of patients are surgical candidates based on preoperative testing results for the laparoscopic LINX antireflux device placement and possible hiatal hernia repair.

    Device: LINX Antireflux

Interventions

  • ProcedureLaparoscopic Fundoplication

    The gastric fundus of the stomach is wrapped or plicated around the lower end of the esophagus and and stitched in place reinforcing the closing function of the lower esophageal sphincter. The hiatus is also narrowed down with sutures or mesh to prevent or treat a concurrent hiatal hernia.

    Also known as: Nissen Fundoplication, Fundoplication, Fundoplasty, Hiatal Hernia Repair, Partial Fundoplication

  • DeviceLINX Antireflux

    The LINX is a flexible band of interlocked titanium beads with a magnetic core. The LINX is placed around the lower esophageal sphincter to help restore the function of the LES by preventing reflux into the esophagus.

    Also known as: LINX System, LINX Implant, LINX Reflux Management System, LINX Magnetic Sphincter Augmentation

06

What researchers measure

Primary outcomes

  1. Quality of Life reported by patient

    Standard GERD Quality of Life Assessment

    Time frame: 5 Years

07

Study locations

19 sites
  • Advanced Surgeons, PC
    Birmingham, Alabama 35243, United States
  • University of Southern Alabama
    Mobile, Alabama 36617, United States
  • The Arkansas Heartburn Treatment Center
    Heber Springs, Arkansas 72543, United States
  • Bass Medical Group
    Walnut Creek, California 94598, United States
  • HealthOne Cardiothoracic Surgery Associates
    Aurora, Colorado 80012, United States
  • Institute of Esophageal and Reflux Surgery
    Englewood, Colorado 80113, United States
  • Suncoast Surgical Associates
    Brandon, Florida 33511, United States
  • South Florida Surgical Specialists, LLC
    Coral Springs, Florida 33065, United States
  • Mayo Clinic
    Jacksonville, Florida 32224, United States
  • Tampa Bay Reflux Center
    Riverview, Florida 33578, United States
  • The Tampa Bay Reflux Center
    Tampa, Florida 33609, United States
  • Coastal Carolina Bariatric and Surgical Center
    Summerville, South Carolina 29485, United States
  • Baylor Scott and White Research Institute
    Dallas, Texas 75204, United States
  • Baylor University Medical Center at Dallas
    Dallas, Texas 75246, United States
  • Houston Methodist Research Institute
    Houston, Texas 77030, United States
  • North Texas Surgical Oncology Associates
    Plano, Texas 75075, United States
  • Swedish Health Services
    Seattle, Washington 98103, United States
  • Affinity Medical Group
    Chilton, Wisconsin 53014, United States
  • Froedtert & The Medical College of Wisconsin Hospitals and Health Partners
    Milwaukee, Wisconsin 53226, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02923362
Lead sponsor
The Heartburn Foundation
Responsible party
Sponsor
First posted
Oct 4, 2016
Start date
May 2016
Primary completion
May 3, 2023
Completion
May 3, 2023
Last update
Aug 7, 2026

Study contacts

Reginald Bell, MD
principal investigator · The Heartburn Foundation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion